Background/Aims: Hemodialysis (HD) patients are less active than their healthy counterparts and frequently experience poor sleep. Our aims were to objectively quantify activity and sleep quality in HD patients of an urban population and to determine the effect of providing feedback on activity. Methods: Activity parameters and sleep parameters were collected by a commercially available activity tracker in 29 chronic HD patients. Patients in the feedback group were provided with their activity and sleep data during each HD treatment. Questionnaires were administered at the beginning and at the end of the study. Results: On average, patients walked 8,454 steps/day and slept 349 min/night. Only 28% of the patients were sedentary, defined as walking <5,000 steps/day. Providing feedback did not increase the activity in this urban population. Patients walked significantly less on Sundays compared to other days of the week: 7,024 steps on Sundays vs. 8,633 steps on HD days and 8,732 on non-HD days. It was also found that patients experienced poor sleep quality. HD treatments during shift 1 (6 a.m. to 10 a.m.) interfered with sleep patterns. Most patients reported that physical activity became more important to them after the 5-week period. The tracking device was very well accepted. Conclusion: Interventions to increase physical activity on Sundays could improve physical activity levels overall. Prospective studies are necessary to further explore the use of tracking devices to identify patients at risk and to implement targeted interventions.

Keywords:
Pervasive sensing, Activity pattern, Sleep pattern
1.
Johansen KL, Chertow GM, Ng AV, Mulligan K, Carey S, Schoenfeld PY, Kent-Braun JA: Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int 2000;57:2564-2570.
2.
Anand S, Chertow GM, Johansen KL, Grimes B, Kurella Tamura M, Dalrymple LS, Kaysen GA: Association of self-reported physical activity with laboratory markers of nutrition and inflammation: the comprehensive dialysis study. J Ren Nutr 2011;21:429-437.
3.
Panaye M, Kolko-Labadens A, Lasseur C, Paillasseur JL, Guillodo MP, Levannier M, Teta D, Fouque D: Phenotypes influencing low physical activity in maintenance dialysis. J Ren Nutr 2015;25:31-39.
4.
O'Hare AM, Tawney K, Bacchetti P, Johansen KL: Decreased survival among sedentary patients undergoing dialysis: results from the dialysis morbidity and mortality study wave 2. Am J Kidney Dis 2003;41:447-454.
5.
Beddhu S, Wei G, Marcus RL, Chonchol M, Greene T: Light-intensity physical activities and mortality in the United States general population and CKD subpopulation. Clin J Am Soc Nephrol 2015;10:1145-1153.
6.
Tudor-Locke CE, Myers AM: Challenges and opportunities for measuring physical activity in sedentary adults. Sports Med 2001;31:91-100.
7.
Nielson R, Vehrs PR, Fellingham GW, Hager R, Prusak KA: Step counts and energy expenditure as estimated by pedometry during treadmill walking at different stride frequencies. J Phys Act Health 2011;8:1004-1013.
8.
Plasqui G, Bonomi AG, Westerterp KR: Daily physical activity assessment with accelerometers: new insights and validation studies. Obes Rev 2013;14:451-462.
9.
Mendoza M, Han M, Meyring-Wösten A, Wilund K, Kotanko P: It's a non-dialysis day... do you know how your patient is doing? A case for research into interdialytic activity. Blood Purif 2015;39:74-83.
10.
Diaz KM, Krupka DJ, Chang MJ, Peacock J, Ma Y, Goldsmith J, Schwartz JE, Davidson KW: Fitbit®: an accurate and reliable device for wireless physical activity tracking. Int J Cardiol 2015;185:138-140.
11.
Tudor-Locke C, Hatano Y, Pangrazi RP, Kang M: Revisiting ‘how many steps are enough?' Med Sci Sports Exerc 2008;40:S537-S543.
12.
How much sleep is enough. https://www.nhlbi.nih.gov/health/health-topics/topics/sdd/howmuch. National Institute of Health, 2012, 2015.
13.
Akerstedt T, Hume K, Minors D, Waterhouse J: The meaning of good sleep: a longitudinal study of polysomnography and subjective sleep quality. J Sleep Res 1994;3:152-158.
14.
Johansen KL, Painter P, Kent-Braun JA, Ng AV, Carey S, Da Silva M, Chertow GM: Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease. Kidney Int 2001;59:1121-1127.
15.
Gomes EP, Reboredo MM, Carvalho EV, Teixeira DR, Carvalho LF, Filho GF, de Oliveira JC, Sanders-Pinheiro H, Chebli JM, de Paula RB, Pinheiro Bdo V: Physical activity in hemodialysis patients measured by triaxial accelerometer. Biomed Res Int 2015;2015:645645.
16.
Ezzat H, Mohab A: Prevalence of sleep disorders among ESRD patients. Ren Fail 2015;37:1013-1019.
17.
Majchrzak KM, Pupim LB, Chen K, Martin CJ, Gaffney S, Greene JH, Ikizler TA: Physical activity patterns in chronic hemodialysis patients: comparison of dialysis and nondialysis days. J Ren Nutr 2005;15:217-224.
18.
Yazdi Z, Sadeghniiat-Haghighi K, Kazemifar AM, Kordi A, Naghipour S: Restless leg syndrome in hemodialysis patients: a disorder that should be noticed. Saudi J Kidney Dis Transpl 2015;26:625-650.
19.
Russcher M, Chaves I, Lech K, Koch BC, Nagtegaal JE, Dorsman KF, Jong A, Kayser M, van Faassen HM, Kema IP, van der Horst GT, Gaillard CA: An observational study on disturbed peripheral circadian rhythms in hemodialysis patients. Chronobiol Int 2015;32:848-857.
20.
Montgomery-Downs HE, Insana SP, Bond JA: Movement toward a novel activity monitoring device. Sleep Breath 2012;16:913-917.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.